Mgat1 - alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase Gene
Species: Rattus norvegicus
Summary
Predicted to enable alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity and manganese ion binding activity. Predicted to be involved in protein N-linked glycosylation via asparagine. Predicted to act upstream of or within UDP-N-acetylglucosamine catabolic process and in utero embryonic development. Predicted to be located in Golgi membrane. Predicted to be active in Golgi apparatus. Orthologous to human MGAT1 (alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase). [provided by Alliance of Genome Resources, Apr 2022]
Mgat1 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_030861.1 | NP_110488.1 | alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase |
|
|
Related Agents
- Clinical Phase
- Pre-clinical Phase
Clinical Phase
| Cat. No. | Product Name |
Effect
|
Purity |
Phase
|
|---|---|---|---|---|
| HY-138942 | PF-06427878 | Inhibitor | / | Phase 1 |
Pre-clinical Phase
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-103504 | (S)-SNAP5114 | Inhibitor | 98.09% | Unkown |
| HY-118207 | LU-32-176B | Inhibitor | / | Unkown |
| HY-155305 | BuChE-IN-9 | Inhibitor | / | Unkown |
| HY-185701 | W-GTF01 | Inhibitor | / | Unkown |
| HY-E70144 | N-Acetylglucosaminyltransferase 1 | / | Unkown | |
| HY-RS08399 | MGAT1 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS08584 | MOGAT1 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS21645 | Mgat1 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS28163 | Mgat1 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service